RGBPP

Regen Biopharma (PK) (RGBPP)

Regen Biopharma Inc (PK)

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:USOTC:RGBPP

1 2 3 4 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/05/30	02 : 12	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	USOTC:RGBPP	Regen Biopharma Inc (PK)
2024/05/30	02 : 11	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:RGBPP	Regen Biopharma Inc (PK)
2024/05/23	22 : 32	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	USOTC:RGBPP	Regen Biopharma Inc (PK)
2024/05/23	22 : 31	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:RGBPP	Regen Biopharma Inc (PK)
2024/05/11	04 : 50	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	USOTC:RGBPP	Regen Biopharma Inc (PK)
2024/05/11	04 : 49	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:RGBPP	Regen Biopharma Inc (PK)
2024/02/10	06 : 15	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	USOTC:RGBPP	Regen Biopharma Inc (PK)
2024/02/10	06 : 14	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:RGBPP	Regen Biopharma Inc (PK)
2024/01/20	03 : 29	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	USOTC:RGBPP	Regen Biopharma Inc (PK)
2024/01/20	03 : 29	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	USOTC:RGBPP	Regen Biopharma Inc (PK)
2023/11/20	23 : 38	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	USOTC:RGBPP	Regen Biopharma Inc (PK)
2023/11/20	23 : 37	Edgar (US Regulatory)	Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]	USOTC:RGBPP	Regen Biopharma Inc (PK)
2023/10/03	02 : 42	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	USOTC:RGBPP	Regen Biopharma Inc (PK)
2023/10/02	13 : 15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	USOTC:RGBPP	Regen Biopharma Inc (PK)
2023/09/26	00 : 25	Edgar (US Regulatory)	Form S-1 - General form for registration of securities under the Securities Act of 1933	USOTC:RGBPP	Regen Biopharma Inc (PK)
2023/09/19	05 : 02	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:RGBPP	Regen Biopharma Inc (PK)
2023/07/26	04 : 39	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	USOTC:RGBPP	Regen Biopharma Inc (PK)
2023/07/25	03 : 59	Edgar (US Regulatory)	Form RW - Registration Withdrawal Request	USOTC:RGBPP	Regen Biopharma Inc (PK)
2023/05/15	23 : 27	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)	USOTC:RGBPP	Regen Biopharma Inc (PK)
2023/05/15	19 : 28	Edgar (US Regulatory)	Notice of Effectiveness (effect)	USOTC:RGBPP	Regen Biopharma Inc (PK)
2023/04/13	19 : 29	Edgar (US Regulatory)	Securities Registration Statement (s-1)	USOTC:RGBPP	Regen Biopharma Inc (PK)
2023/03/22	02 : 52	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:RGBPP	Regen Biopharma Inc (PK)
2023/02/07	21 : 14	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:RGBPP	Regen Biopharma Inc (PK)
2023/01/20	05 : 42	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:RGBPP	Regen Biopharma Inc (PK)
2022/11/22	07 : 12	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:RGBPP	Regen Biopharma Inc (PK)
2022/11/18	20 : 37	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:RGBPP	Regen Biopharma Inc (PK)
2022/11/16	05 : 38	Edgar (US Regulatory)	Annual Report (10-k)	USOTC:RGBPP	Regen Biopharma Inc (PK)
2022/11/15	02 : 06	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:RGBPP	Regen Biopharma Inc (PK)
2022/09/20	20 : 04	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:RGBPP	Regen Biopharma Inc (PK)
2022/07/23	03 : 43	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:RGBPP	Regen Biopharma Inc (PK)